Gore & Associates: Grant/Research Support, Slingshot Insights: Consultant, AlphaSights: Consultant, Gerson Lehrman Group: Consultant, Medicolegal consulting: medicolegal consulting, Amit Singal: Genentech: Consultant, AstraZeneca: Consultant, Bayer: Consultant, Eisai: Consultant, Exelixis: Consultant, Merck: Consultant, Elevar: Consultant, FujiFilm Medical Sciences: Consultant, Exact Sciences: Consultant, Glycotest: Consultant, Boston Scientific: Consultant, Sirtex: Consultant, HistoSonics: Consultant, Sarah Lieber: Nothing to Disclose 1761 INADEQUATE VIRAL HEPATITIS IMMUNIZATION AND TESTING AMONGST VULNERABLE PATIENTS IN THE AMBULATORY SETTING Chip Bowman 1 Elizabeth Verna 1 , 1 Columbia University Medical Center Background: This study addresses the goal set by the WHO to eliminate viral hepatitis as a public health threat by 2030, emphasizing the need for continued efforts despite recent declines in hepatitis A and B infections in the United States

Because Dihexa promotes structural changes in synaptic density and neural connections, effects often persist beyond treatment duration, allowing for cycling approaches rather than continuous use
Mechanotransduction activates 51 integrin and PI3K/Akt signaling pathways in mandibular osteoblasts
The focus is on palliative care, not curative care